Evolution AB/ SE0012673267 /
2024-06-05 5:24:53 PM | Chg. - | Volume | Bid5:25:00 PM | Ask5:25:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,134.50SEK | - | 87,549 Turnover: 53.6 mill. |
-Bid Size: - | -Ask Size: - | 244.28 bill.SEK | - | - |
GlobeNewswire
9:52 PM
Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immu...
GlobeNewswire
8:01 PM
Third RAPID + TCT Executive Perspectives Session to Emphasize Innovation and Applications Driving Ad...
GlobeNewswire
1:30 PM
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
05-31
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authoriza...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
Newsfile Corp
05-30
Eywa, Dubai by R.Evolution, Wins the Title of World's Best Property, 2023-24, and Best International...
GlobeNewswire
05-22
Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-...
GlobeNewswire
05-21
NewHydrogen CEO Steve Hill Discusses Development of Standalone Hydrogen Evolution System with SDSU E...
GlobeNewswire
05-20
XPENG launches industry's first AI-powered in-car OS, promoting AI-enabled smart driving experience
GlobeNewswire
05-20
Integrated Access Corporation rebrands as Xpand Demand™, positioning itself as a multifaceted indust...
GlobeNewswire
05-20
Shimmick Takes Pivotal Steps to Further Advance Evolution as Leader in Water Infrastructure
GlobeNewswire
05-14
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting